Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-05-05
1999-03-30
Shah, Mukund J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514255, 514320, 514342, 514343, 514364, 514376, 514414, 514422, 544369, 544373, 544376, 546196, 5462697, 5462764, 548144, 548183, 548227, 548468, 548525, A61K 31425, A61K 31395, C07D27734, C07D41702
Patent
active
058890327
ABSTRACT:
The present invention relates to novel antidiabetic compounds, their tautomeric forms, their derivatives, their stereoisomers, their polymorphs, their pharmaceutically acceptable salts, their pharmaceutically acceptable solvates and pharmaceutically acceptable compositions containing them. This invention particularly relates to novel azolidinedione derivatives of the general formula (I), and their pharmaceutically acceptable salts, pharmaceutically acceptable solvates and pharmaceutical compositions containing them. ##STR1##
REFERENCES:
patent: 4342771 (1982-08-01), Schnur
patent: 4367234 (1983-01-01), Schnur
patent: 4725610 (1988-02-01), Meguro
patent: 4873255 (1989-10-01), Yoshioka
patent: 5002953 (1991-03-01), Hindley
patent: 5036079 (1991-07-01), Clark
patent: 5037842 (1991-08-01), Goldstein
patent: 5130379 (1992-07-01), Clark
patent: 5153210 (1992-10-01), Ainsworth
patent: 5296605 (1994-03-01), De Nanteuil
patent: 5330999 (1994-07-01), De Nanteuil
patent: 5420146 (1995-05-01), Malamas
patent: 5468762 (1995-11-01), Malamas
patent: 5478851 (1995-12-01), Cantello
patent: 5478852 (1995-12-01), Olefsky
patent: 5478853 (1995-12-01), Regnier
patent: 5480896 (1996-01-01), Malamas
patent: 5498621 (1996-03-01), Dow
patent: 5521201 (1996-05-01), Hindley
patent: 5521202 (1996-05-01), Yano
English Translation of JP-A-0912575, 1997.
Khan, A., et al., "Synthesis and Antibacterial Activity of Some New 2-aryloxymethyl-3-substituted-quinazollin-4 (3H)-ones" Pharmazie vol. 43, No. 12, pp. 864-865, 1998.
Chemical Abstracts, vol. 93, No. 17, Oct. 27, 1980, No. 168217.
Shukla, J.S., et al. "Synthesis of 2-phenoxymethyl-3-(2'-pyridyl/thiazolyl)-4-quinazolones as Possible Antifertility Drugs" Indian Journal Chemical, vol. 17B, No. 6, pp. 651-652, Jun. 1979.
Husain, M.I., et al., "Some New 2-aryloxymethyl-3-.alpha.-substituted carboxymethyl-6,8 substituted 4-quinazolones as Possible Anticonvulsants", Pharmazie, vol. 37, No. 6, 1982, pp. 408-410.
G. De Nanteuil, "Euglygaemic and Biological Activities of Novel Thiazolidine-2,4-dione Derivatives" Arzneittel Forschung/Drug Design, vol. 45, No. II, 1995, pp. 1176-1181.
Whitcomb, R.W., "Thiazolidinediones", Expert Opinion on Investigational Drugs, vol.4, No. 12, Dec. 1995, pp. 1299-1309.
Modan, Michaela, et al. "Hyperinsulinemia A Link Between Hypertension Obesity and Glucose Intolerance." The American Society for Clinical Investigation, vol. 75 (Mar. 1985), pp. 809-817.
Kolterman, O. G., et al. "Receptor and Postreceptor Defects Contibute to the Insulin Resistance in Noninsulin-dependent Diabetes Mellitus." The American Society for Clinical Investigation, vol. 68 (Oct. 1981), pp. 957-969.
Ferrannini, E., et al. "Insulin Resistance in Essential Hypertension." The New England Journal of Medicine, vol. 317, No. 6 (Aug. 1987), pp. 350-357.
Shen, D. C., et al. "Resistance to Insulin-Stimulated-Glucose Uptake in Patients with Hypertension." Journal of Clinical Endocrinology and Metabolism, vol. 66, No. 3 (1988), pp. 580-583.
Cantello, Barrie C. C., et al. "(Heterocyclylamino) alkoxy!benzyl!-2,4-thiazolidinediones and Potent Antihyperglycemic Agents." Journal of Medicinal Chemistry, vol. 37, No. 23 (1994), pp. 3977-3985.
Antonucci, T., et al. "Impaired Glucose Tolerance is Normalized by Treatment with the Thiazolidinedione Troglitazone." Diabetes Care, vol. 20, No. 2 (Feb. 1997), pp. 188-193.
Bailey, C. J. "Potential new treatments for type 2 diabetes." Chemistry and Industry, (Jan. 1998), pp. 53-57.
"Hormones and Hormone Antagonists" Goodman & Gilman's The Pharmacological Baisis of Therapeutics, Ninth Edition, Section XIII. pp. 1496-1497, 1996.
Hulin, B., et al. "Hypoglycemic Activity of a Series of a-Alkylthio and a-Alkoxy Carboxylic Acids Related to Ciglitazone." Journal of Medicinal Chemistry, vol. 39, No. 20 (1996), pp. 3897-3907.
Behavioral Brain Research, 75 (1996) pp. 1-11, Messier, et al.
Chemical Pharmaceutical Bulletin, vol. 30, No. 10, 1982 pp. 3580-3600, Taskasi Sohda, et al.
D.A. Clark et al., "Substituted Dihydrobenzeopran . . . ", J. Med. Chem. 1991, 34, 319-325.
R.L. Dow et al., "Benzyloxzolidine-2,4-diones . . . ", J. Med. Chem. 1991, 34, 1538-1544.
S.W. Goldstein et al., "Hydroxyurea Derivatives . . . ", J. Med. Chem. 1993, 36, 2238-2240.
B. Hulin et al., "Novel Thiazolidine . . . ", J. Med. Chem. 1992, vol. 35, No. 10, 1853-1864.
Journal of Medicinal Chemistry, vol. 37, No. 23, 1994, Barrie, CC. Et al., pp. 3977-3985.
T. Sohda et al., "Studies on Antidiabetic . . . ", J. Med. Chem., 1992, vol. 35, No. 14, 2617-2626.
Alla Sekar Reddy
Bajji Ashok Channaveerappa
Chakrabarti Ranjan
Lohray Braj Bhushan
Lohray Vidya Bhushan
Coleman Brenda
Dr. Reddy's Research Foundation
Reddy-Cheminor Inc.
Shah Mukund J.
LandOfFree
Heterocyclic compounds having antidiabetic, hypolipidaemic, anti does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic compounds having antidiabetic, hypolipidaemic, anti, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic compounds having antidiabetic, hypolipidaemic, anti will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1215497